⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11029381 | 0.97 | — | — | |
| SCHEMBL2827340 | 0.89 | TSHR (0.32) | — | |
| SCHEMBL2833245 | 0.89 | — | — | |
| SCHEMBL2831752 | 0.87 | TSHR (0.36) | — | |
| SCHEMBL2832088 | 0.87 | TSHR (0.36) | — | |
| SCHEMBL1840485 | 0.87 | TSHR (0.36) | — | |
| SCHEMBL4624265 | 0.83 | KDM4E (0.36) | — | |
| SCHEMBL6614400 | 0.82 | ALDH1A1 (0.32) | — | |
| SCHEMBL5674805 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL16666609 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3169403-B9 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2024-07-03 | — | — | EP | claimed |
| EP-3891176-B1 | DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE | HOLST BIRGITTE (DK) | 2024-06-05 | — | — | EP | claimed |
| EP-3169403-B1 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2024-02-14 | — | — | EP | claimed |
| EP-3250191-B1 | TABLETS COMPRISING GLP-1 AGONIST AND ENTERIC COATING | NOVO NORDISK AS (DK) | 2024-01-17 | — | — | EP | claimed |
| EP-2637698-B1 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | NOVO NORDISK AS (DK) | 2022-04-20 | — | — | EP | claimed |
| EP-3600279-B1 | 1-AMINO-1-CYCLOPROPANECABOXYLIC ACID FORMULATIONS | VALENT BIOSCIENCES LLC (US) | 2022-03-09 | — | — | EP | claimed |
| EP-2932981-B1 | Albumin-binding derivatives of GLP-1 | NOVO NORDISK AS (DK) | 2021-06-16 | — | — | EP | claimed |
| EP-3515191-B1 | A METHOD FOR INCREASING ANTHOCYANIN CONTENT IN CARROTS | UNIV COPENHAGEN (DK) | 2021-03-17 | — | — | EP | claimed |
| EP-3225631-B1 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | NOVO NORDISK AS (DK) | 2019-01-09 | — | — | EP | claimed |
| EP-2637699-B1 | DOUBLE-ACYLATED GLP-1 DERIVATIVES WITH A LINKER | NOVO NORDISK AS (DK) | 2018-05-16 | — | — | EP | claimed |
| EP-0958305-B1 | INHIBITIONS OF THE INTERACTION BETWEEN P53 AND MDM2 | CANCER REC TECH LTD (GB) | 2008-06-04 | — | — | EP | claimed |
| EP-0533832-B1 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | US SECRETARY UNITED STATES DEP (US) | 2002-11-20 | — | — | EP | claimed |
| EP-0528970-B1 | METHODS AND COMPOSITIONS FOR MODULATING ETHYLENE LEVELS IN PLANT TISSUES | CALGENE LLC (US) | 1999-07-07 | — | — | EP | claimed |
| EP-0552417-B1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-07-07 | — | — | EP | claimed |
| EP-0920307-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1999-06-09 | — | — | EP | claimed |
| EP-0767607-B1 | USE OF COMPOUNDS WHICH INHIBIT EHTYLENE BIOSYNTHESIS IN HIGHER PLANTS FOR SOIL IMPROVEMENT | BASF AG (DE) | 1998-11-25 | — | — | EP | claimed |
| WO-1998006386-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | ROCHE DIAGNOSTICS GMBH (DE) | 1998-02-19 | — | — | WO | claimed |
| EP-0528312-B1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-07-16 | — | — | EP | claimed |
| EP-0135429-B1 | THE SYNTHESIS OF CYCLOPROPANE AMINO ACIDS AND PEPTIDES | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1992-03-18 | — | — | EP | claimed |
| EP-0036713-B1 | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | UNIVERSITY OF MIAMI (US) | 1984-01-18 | — | — | EP | claimed |